Press Release Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week 7 hours ago
Press Release Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Jul 30